Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$11.94 - $20.47 $13,038 - $22,353
-1,092 Reduced 7.26%
13,953 $277,000
Q3 2023

Nov 14, 2023

SELL
$16.3 - $22.09 $34,572 - $46,852
-2,121 Reduced 12.36%
15,045 $245,000
Q2 2023

Aug 14, 2023

SELL
$19.41 - $23.43 $33,229 - $40,112
-1,712 Reduced 9.07%
17,166 $363,000
Q1 2023

May 15, 2023

BUY
$18.06 - $25.27 $340,936 - $477,047
18,878 New
18,878 $379,000

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.75B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Parkwood LLC Portfolio

Follow Parkwood LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkwood LLC with notifications on news.